Use of recombinant human follicle-stimulating hormone in the treatment of male factor infertility

By Foresta C.   Bettella A.   Merico M.   Garolla A.   Ferlin A.   Rossato M.  

Fertility and Sterility, Vol. 77, Iss. 2, 2002-02 ,pp. : 238-244

Elsevier

Access to resources Recommend Favorite

Low-dose human chorionic gonadotropin therapy can improve sensitivity to exogenous follicle-stimulating hormone in patients with secondary amenorrhea - a dose-finding study

By Filicori M.   Cognigni G.E.   Taraborrelli S.   Spettoli D.   Ciampaglia W.   Tabarelli de Fatis C.  

Fertility and Sterility, Vol. 72, Iss. 6, 1999-12 ,pp. : 1118-1120

Elsevier

Access to resources Recommend Favorite

Recombinant follicle-stimulating hormone versus human menopausal gonadotropin in the late follicular phase during ovarian hyperstimulation for in vitro fertilization

By Commenges-Ducos M.   Piault S.   Papaxanthos A.   Ribes C.   Dallay D.   Commenges D.  

Fertility and Sterility, Vol. 78, Iss. 5, 2002-11 ,pp. : 1049-1054

Elsevier

Access to resources Recommend Favorite

Methodologic pitfalls in assessing the efficacy of recombinant follicle-stimulating hormone versus human menopausal gonadotropin in assisted reproduction

By Daya S.  

Fertility and Sterility, Vol. 80, Iss. 5, 2003-11 ,pp. : 1100-1104

Elsevier

Access to resources Recommend Favorite

Efficacy and safety of recombinant human follicle-stimulating hormone in men with isolated hypogonadotropic hypogonadism

By Bouloux P.   Warne D.W.   Loumaye E.   for the FSH Study Group in Male Infertility  

Fertility and Sterility, Vol. 77, Iss. 2, 2002-02 ,pp. : 270-273

Elsevier

Access to resources Recommend Favorite